Arrhythmogenic cardiomyopathy: pathogenesis, pro-arrhythmic remodelling, and novel approaches for risk stratification and therapy
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Arrhythmogenic cardiomyopathy (ACM) is a life-threatening cardiac disease caused by mutations in genes predominantly encoding for desmosomal proteins that lead to alterations in the molecular composition of the intercalated disc. ACM is characterized by progressive replacement of cardiomyocytes by fibrofatty tissue, ventricular dilatation, cardiac dysfunction, and heart failure but mostly dominated by the occurrence of life-threatening arrhythmias and sudden cardiac death (SCD). As SCD appears mostly in apparently healthy young individuals, there is a demand for better risk stratification of suspected ACM mutation carriers. Moreover, disease severity, progression, and outcome are highly variable in patients with ACM. In this review, we discuss the aetiology of ACM with a focus on pro-arrhythmic disease mechanisms in the early concealed phase of the disease. We summarize potential new biomarkers which might be useful for risk stratification and prediction of disease course. Finally, we explore novel therapeutic strategies to prevent arrhythmias and SCD in the early stages of ACM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., Galuppo, P., Just, S., Rottbauer, W., Frantz, S., et al. (2008) · Nature · doi:10.1038/nature07511 · Cited by 2,349 · cited 1×
“In contrast to the effect of miR-21 on fibroblasts, it apparently does not modify cardiomyocyte function or morphology.(101) A second miRNA involved in regu-”
BackgroundStrimbu, K., & Tavel, J. A. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32833ed177 · Cited by 2,062
Corrado, D., Basso, C., Thiene, G., McKenna, W. J., Davies, M. J., Fontaliran, F., Nava, A., Silvestri, F., Blomstrom-Lundqvist, C., Wlodarska, E. K., et al. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00332-x · Cited by 978 · cited 5×
“An LV involvement has been reported in series addressing the typical RV variants of ACM, with up to 50–76% of the ACM hearts studied at post-mortem disclosing alterations in the LV.27,30 In recent years, genotype–phenotype correlation studies led to the awareness that left dominant or even isolated LV forms of ACM do…”
BackgroundInfluentialSelf-citationArrhythmogenic Right Ventricular Cardiomyopathy: Dysplasia, Dystrophy, or Myocarditis?
Basso, C., Thiene, G., Corrado, D., Angelini, A., Nava, A., & Valente, M. (1996) · Circulation · doi:10.1161/01.cir.94.5.983 · Cited by 890
Self-citationA New Diagnostic Test for Arrhythmogenic Right Ventricular Cardiomyopathy
Asimaki, A., Tandri, H., Huang, H., Halushka, M. K., Gautam, S., Basso, C., Thiene, G., Tsatsopoulou, A., Protonotarios, N., McKenna, W. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808138 · Cited by 456
Self-citationCorrado, D., van Tintelen, P. J., McKenna, W. J., Hauer, R. N. W., Anastastakis, A., Asimaki, A., Basso, C., Bauce, B., Brunckhorst, C., Bucciarelli-Ducci, C., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz669 · Cited by 366
Self-citationChen, S. N., Gurha, P., Lombardi, R., Ruggiero, A., Willerson, J. T., & Marian, A. J. (2014) · Circulation Research · doi:10.1161/circresaha.114.302810 · Cited by 275 · cited 3×
“In human and mouse ACM hearts as well as PKP2-deficient HL-1 myocytes, activation of the Hippo pathway has been observed, including phosphorylation and cytoplasmic retention of YAP.68 YAP interacts with b-catenin, thereby suppressing its nuclear translocation and subsequent Wnttarget gene expression.69 Thus, elevated…”
BackgroundAsimaki, A., Kapoor, S., Plovie, E., Karin Arndt, A., Adams, E., Liu, Z., James, C. A., Judge, D. P., Calkins, H., Churko, J., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008008 · Cited by 274 · cited 6×
“In addition, in ACM fish treated with SB216763, maladaptive remodelling of ion channels underlying action potential formation was reversed.(55) Comparable results were obtained in a mouse model which expressed patient-specific mutations in Ank2,(119) in cultured buccal mucosa cells,(44) in neonatal rat ventricular myo…”
BackgroundResultInfluentialSelf-citationPlakophilin-2 Is Required for Transcription of Genes That Control Calcium Cycling and Cardiac Rhythm
Cerrone, M., Montnach, J., Lin, X., Zhao, Y.-T., Zhang, M., Agullo-Pascual, E., Leo-Macias, A., Alvarado, F. J., Dolgalev, I., Karathanos, T. V., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00127-0 · Cited by 210 · cited 4×
“The summation of these alterations in calcium handling proteins functionally resulted in an increased sarcoplasmic reticulum (SR) calcium load, a higher diastolic [Ca2þ], and a high propensity for early or late after-depolarization.88 Moreover, flecainide treatment reduced the occurrence of arrhythmias; in addition to…”
BackgroundInfluentialPilichou, K., Remme, C. A., Basso, C., Campian, M. E., Rizzo, S., Barnett, P., Scicluna, B. P., Bauce, B., van den Hoff, M. J. B., de Bakker, J. M. T., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090641 · Cited by 210
Self-citation
Cited by
Lin, Y.-N., Mesquita, T., Sanchez, L., Chen, Y.-H., Liu, W., Li, C., Rogers, R., Wang, Y., Li, X., Wu, D., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab419 · Cited by 83
Vanaja, I. P., Scalco, A., Ronfini, M., Bona, A. D., Olianti, C., Rizzo, S., Chelko, S. P., Corrado, D., Sacconi, L., Basso, C., et al. (2025) · The Journal of Physiology · doi:10.1113/jp286845 · Cited by 17
Self-citationHistopathological Features and Protein Markers of Arrhythmogenic Cardiomyopathy
Bueno-Beti, C., & Asimaki, A. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.746321 · Cited by 12
Maione, A. S., Iengo, L., Sala, L., Massaiu, I., Chiesa, M., Lippi, M., Ghilardi, S., Florindi, C., Lodola, F., Zaza, A., et al. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02232-8 · Cited by 4
“The latter mechanism becomes evident in advanced stages of ACM, where extensive structural alterations ( fi bro-fatty accumulation, mainly caused by cMSC) slow down electrical signal conduction, contributing to re-entrant circuits [33].”
Yeh, Y.-H., Ko, Y.-S., Chan, Y.-H., Lai, Y.-J., Chang, G.-J., Chang, C.-J., & Hsu, L.-A. (2026) · Circulation: Genomic and Precision Medicine · doi:10.1161/circgen.125.005434 · Cited by 3
Metadata
- Authors
- van der Voorn, S. M., te Riele, A. S. J. M., Basso, C., Calkins, H., Remme, C. A., & van Veen, T. A. B.
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-04-04
- Volume
- 116
- Issue
- 9
- Pages
- 1571-1584
- ISSN
- 0008-6363 (ISSN-L)
- 1755-3245
- OpenAlex
- W3014543651
- Cited by
- 62
- References
- 17
- FWCI
- 5.03
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.